Indian J Pharm Close
 

Table 14: Question 4 (iv): In a patient with no visceral crisis who has progressed on everolimus and exemestane and in whom you are considering next line endocrine therapy, would you continue everolimus beyond progression?

Table 14: Question 4 (iv): In a patient with no visceral crisis who has progressed on everolimus and exemestane and in whom you are considering next line endocrine therapy, would you continue everolimus beyond progression?